John Saharek
Corporate Officer/Principal bij HARROW, INC.
Vermogen: 2 M $ op 30-04-2024
Profiel
John P.
Saharek is currently the President & Chief Executive Officer at ImprimisRx LLC since 2012 and the Chief Commercial Officer at Harrow, Inc. since 2012.
Previously, he worked as the Vice President-Business Development at Surmodics, Inc. from 2006 to 2011.
He also held the position of Head-US Marketing & Strategy at Thrombogenics, Inc. Mr. Saharek completed his undergraduate degree at Central Connecticut State University and obtained an MBA from the University of Hartford.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
HARROW, INC.
0.71% | 16-04-2024 | 249 803 ( 0.71% ) | 2 M $ | 30-04-2024 |
Actieve functies van John Saharek
| Bedrijven | Functie | Begin |
|---|---|---|
| HARROW, INC. | Corporate Officer/Principal | 01-02-2015 |
| ImprimisRx LLC | Algemeen Directeur | 02-01-2024 |
Eerdere bekende functies van John Saharek
| Bedrijven | Functie | Einde |
|---|---|---|
| SURMODICS, INC. | Corporate Officer/Principal | 01-07-2011 |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Verkoop & Marketing | - |
Opleiding van John Saharek
| Central Connecticut State University | Undergraduate Degree |
| University of Hartford | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SURMODICS, INC. | Health Technology |
| HARROW, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| ImprimisRx LLC | |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Commercial Services |